AbbVie's TEPKINLY (epcoritamab) combination approved in Europe to treat relapsed or refractory follicular lymphoma

AMO Pharma updates on scientific advice for AMO-02 registrational clinical study in congenital myotonic dystrophy type 1

IceCure reports growing adoption of ProSense cryoablation in Brazil

Aurinia initiates PRESERVE Phase 4 study of LUPKYNIS combination therapy in lupus nephritis

Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology

Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer

Neurocrine Biosciences initiates crinecerfont Phase 2 study in young children with classic CAH

PharmaResearch to acquire CG USA to support North American expansion of REJURAN Cosmetics

Co-Diagnostics advances toward FDA filing after completing clinical validation for respiratory point-of-care test

Hansa Biopharma closes EUR115m Licensing Deal with SERB Pharmaceuticals for Idefirix

SciBase submits FDA filing to expand Nevisense use to non‑melanoma skin cancers

Galderma receives FDA Complete Response Letter for RelabotulinumtoxinA US filing

AbbVie receives positive CHMP opinion for upadacitinib in severe alopecia areata

AbbVie receives positive CHMP opinion for upadacitinib in non‑segmental vitiligo

genedrive partners with Thermo Fisher Scientific to develop high-throughput CYP2C19 test